| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911006 | Lung Cancer | 2014 | 6 Pages |
Abstract
The data from over 6000 patients was consistent with the results of the ICOGEN study. Icotinib demonstrated a favorable toxicity profile and efficacy in the routine clinical setting.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xingsheng Hu, Baohui Han, Aiqin Gu, Yiping Zhang, Shun Chang Jiao, Chang-li Wang, Jintao He, Xueke Jia, Li Zhang, Jiewen Peng, Meina Wu, Kejing Ying, Junye Wang, Kewei Ma, Shucai Zhang, Changxuan You, Fenlai Tan, Yinxiang Wang, Yan Sun,